Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 239
7
Diseases
174
Unique genes
0.090
Avg. similarity score
Cholecystolithiasis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cholecystolithiasis
Gallstones
Cholecystitis
cone-rod dystrophy 20
johanson-blizzard syndrome
Adenylosuccinate lyase deficiency
Mucosulfatidosis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cholecystolithiasis | 5 | 5 | 142 |
| Gallstones | 3 | 3 | 124 |
| Cholecystitis | 2 | 2 | 12 |
| cone-rod dystrophy 20 | 2 | 2 | 1 |
| johanson-blizzard syndrome | 2 | 2 | 1 |
| Adenylosuccinate lyase deficiency | 1 | 1 | 1 |
| Mucosulfatidosis | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCG8 | 3 / 7 | Cholecystitis, Cholecystolithiasis, Gallstones |
| POC1B | 3 / 7 | Cholecystolithiasis, cone-rod dystrophy 20, Gallstones |
| SUMF1 | 3 / 7 | Cholecystitis, Cholecystolithiasis, Mucosulfatidosis |
| UBR1 | 3 / 7 | Cholecystolithiasis, Gallstones, johanson-blizzard syndrome |
| ABCB1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ABCB4 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ABCG5 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ABO | 2 / 7 | Cholecystolithiasis, Gallstones |
| ADAM19 | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| ADAR | 2 / 7 | Cholecystolithiasis, Gallstones |
| ADSL | 2 / 7 | Adenylosuccinate lyase deficiency, Cholecystolithiasis |
| ANO1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ANPEP | 2 / 7 | Cholecystolithiasis, Gallstones |
| AP1S3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| APOE | 2 / 7 | Cholecystolithiasis, Gallstones |
| ARHGEF3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ARPC2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ATG16L2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| ATP8B1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| BANF2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| CCK | 2 / 7 | Cholecystolithiasis, Gallstones |
| CCN3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| CLDN7 | 2 / 7 | Cholecystolithiasis, Gallstones |
| CPS1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| CRBN | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| CYB5B | 2 / 7 | Cholecystolithiasis, Gallstones |
| CYP7A1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| DAGLB | 2 / 7 | Cholecystolithiasis, Gallstones |
| DDX17 | 2 / 7 | Cholecystolithiasis, Gallstones |
| DLD | 2 / 7 | Cholecystolithiasis, Gallstones |
| DMC1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| DYRK1A | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| EHF | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| FADS1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FADS2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FARP2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FBXO46 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FHIP2B | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| FOXA3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FRAT2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FUT2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FUT3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| FUT6 | 2 / 7 | Cholecystolithiasis, Gallstones |
| GATA4 | 2 / 7 | Cholecystolithiasis, Gallstones |
| GCKR | 2 / 7 | Cholecystolithiasis, Gallstones |
| GIPR | 2 / 7 | Cholecystolithiasis, Gallstones |
| GNAS | 2 / 7 | Cholecystolithiasis, Gallstones |
| GPBAR1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| GPC1 | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| GPR61 | 2 / 7 | Cholecystolithiasis, Gallstones |
| HMGCR | 2 / 7 | Cholecystolithiasis, Gallstones |
| HNF1A | 2 / 7 | Cholecystolithiasis, Gallstones |
| HNF1B | 2 / 7 | Cholecystolithiasis, Gallstones |
| HNF4A | 2 / 7 | Cholecystolithiasis, Gallstones |
| IRF2BP1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| JMJD1C | 2 / 7 | Cholecystolithiasis, Gallstones |
| KCNJ6 | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| KDELR2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| KDELR3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| KDM4C | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| LARP1 | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| LIAS | 2 / 7 | Cholecystolithiasis, Gallstones |
| LIN28B | 2 / 7 | Cholecystolithiasis, Gallstones |
| LITAF | 2 / 7 | Cholecystolithiasis, Gallstones |
| LRBA | 2 / 7 | Cholecystolithiasis, Gallstones |
| MARCHF8 | 2 / 7 | Cholecystolithiasis, Gallstones |
| MLLT10 | 2 / 7 | Cholecystolithiasis, Gallstones |
| MLXIPL | 2 / 7 | Cholecystolithiasis, Gallstones |
| MUC5AC | 2 / 7 | Cholecystolithiasis, Gallstones |
| NFAT5 | 2 / 7 | Cholecystolithiasis, Gallstones |
| NUP153 | 2 / 7 | Cholecystolithiasis, Gallstones |
| PNKD | 2 / 7 | Cholecystolithiasis, Gallstones |
| PNPLA3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| PTTG1IP | 2 / 7 | Cholecystolithiasis, Gallstones |
| RMI2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| RRP12 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SERPINA1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SH3BP4 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SHROOM3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SKIDA1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SLC10A2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SNX9 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SULT2A1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SYNJ2 | 2 / 7 | Cholecystolithiasis, Gallstones |
| SYT16 | 2 / 7 | Cholecystolithiasis, Gallstones |
| TM4SF4 | 2 / 7 | Cholecystolithiasis, Gallstones |
| TMBIM1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| TMEM132C | 2 / 7 | Cholecystitis, Cholecystolithiasis |
| TMEM147 | 2 / 7 | Cholecystolithiasis, Gallstones |
| TNRC6B | 2 / 7 | Cholecystolithiasis, Gallstones |
| TRAF3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| TTC39B | 2 / 7 | Cholecystolithiasis, Gallstones |
| UBXN2B | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGDH | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A1 | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A10 | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A3 | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A4 | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A5 | 2 / 7 | Cholecystolithiasis, Gallstones |
| UGT1A6 | 2 / 7 | Cholecystolithiasis, Gallstones |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bile secretion | KEGG | 22 / 90 | 16.9× | 2.06e-21 | 2.11e-18 ✓ sig. |
| Ascorbate and aldarate metabolism | KEGG | 10 / 30 | 23.0× | 7.35e-12 | 1.36e-9 ✓ sig. |
| Glucuronidation | Reactome | 9 / 22 | 28.2× | 9.67e-12 | 1.74e-9 ✓ sig. |
| Pentose and glucuronate interconversions | KEGG | 10 / 36 | 19.2× | 5.77e-11 | 8.73e-9 ✓ sig. |
| Steroid hormone biosynthesis | KEGG | 11 / 63 | 12.1× | 1.38e-9 | 1.47e-7 ✓ sig. |
| Porphyrin metabolism | KEGG | 9 / 46 | 13.5× | 1.59e-8 | 1.31e-6 ✓ sig. |
| Chemical carcinogenesis - DNA adducts | KEGG | 10 / 70 | 9.9× | 5.89e-8 | 4.13e-6 ✓ sig. |
| Metabolism of xenobiotics by cytochrome P450 | KEGG | 10 / 79 | 8.7× | 1.91e-7 | 1.15e-5 ✓ sig. |
| Biosynthesis of cofactors | KEGG | 13 / 154 | 5.8× | 3.51e-7 | 1.97e-5 ✓ sig. |
| Retinol metabolism | KEGG | 9 / 68 | 9.1× | 5.41e-7 | 2.87e-5 ✓ sig. |
| Drug metabolism - cytochrome P450 | KEGG | 9 / 73 | 8.5× | 1.00e-6 | 4.88e-5 ✓ sig. |
| Drug metabolism - other enzymes | KEGG | 9 / 81 | 7.7× | 2.44e-6 | 1.05e-4 ✓ sig. |
| PPARA activates gene expression | Reactome | 9 / 115 | 5.4× | 4.31e-5 | 1.13e-3 ✓ sig. |
| ABC transporters | KEGG | 6 / 45 | 9.2× | 4.32e-5 | 1.14e-3 ✓ sig. |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | Reactome | 5 / 37 | 9.3× | 1.80e-4 | 3.61e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| negative regulation of fatty acid metabolic process | GO:0045922 | 8 / 11 | 78.1× | 7.74e-15 | 5.09e-12 ✓ sig. |
| flavone metabolic process | GO:0051552 | 5 / 5 | 107× | 6.61e-11 | 1.98e-8 ✓ sig. |
| xenobiotic metabolic process | GO:0006805 | 12 / 120 | 10.7× | 1.28e-9 | 2.80e-7 ✓ sig. |
| lipid metabolic process | GO:0006629 | 28 / 840 | 3.6× | 4.18e-9 | 7.96e-7 ✓ sig. |
| steroid metabolic process | GO:0008202 | 12 / 135 | 9.5× | 4.97e-9 | 9.29e-7 ✓ sig. |
| flavonoid metabolic process | GO:0009812 | 5 / 12 | 44.7× | 4.96e-8 | 6.74e-6 ✓ sig. |
| triglyceride homeostasis | GO:0070328 | 6 / 38 | 17.0× | 1.29e-6 | 1.01e-4 ✓ sig. |
| retinoic acid metabolic process | GO:0042573 | 5 / 25 | 21.5× | 3.02e-6 | 2.00e-4 ✓ sig. |
| cholesterol homeostasis | GO:0042632 | 8 / 112 | 7.7× | 1.00e-5 | 5.24e-4 ✓ sig. |
| lipid transport | GO:0006869 | 10 / 189 | 5.7× | 1.13e-5 | 5.74e-4 ✓ sig. |
| lipid homeostasis | GO:0055088 | 6 / 55 | 11.7× | 1.19e-5 | 5.96e-4 ✓ sig. |
| liver development | GO:0001889 | 7 / 87 | 8.6× | 1.68e-5 | 7.83e-4 ✓ sig. |
| response to nutrient | GO:0007584 | 6 / 63 | 10.2× | 2.62e-5 | 1.10e-3 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 7 / 107 | 7.0× | 6.41e-5 | 2.17e-3 ✓ sig. |
| negative regulation of intestinal phytosterol absorption | GO:0010949 | 2 / 2 | 107× | 8.62e-5 | 2.71e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cholecystolithiasis | Gallstones | 0.526 | 92 | 2.74e-175 | 7.09e-173 ✓ sig. |
| Cholecystitis | Cholecystolithiasis | 0.084 | 12 | 2.36e-25 | 6.19e-24 ✓ sig. |
| Cholecystitis | Mucosulfatidosis | 0.077 | 1 | 7.79e-4 | 1.39e-3 ✓ sig. |
| cone-rod dystrophy 20 | Gallstones | 0.008 | 1 | 8.05e-3 | 9.36e-3 ✓ sig. |
| Gallstones | johanson-blizzard syndrome | 0.008 | 1 | 8.05e-3 | 9.36e-3 ✓ sig. |
| Adenylosuccinate lyase deficiency | Cholecystolithiasis | 0.007 | 1 | 9.22e-3 | 1.05e-2 ✓ sig. |
| Cholecystolithiasis | cone-rod dystrophy 20 | 0.007 | 1 | 9.22e-3 | 1.05e-2 ✓ sig. |
| Cholecystolithiasis | johanson-blizzard syndrome | 0.007 | 1 | 9.22e-3 | 1.05e-2 ✓ sig. |